Company to Participate in BIO Partnering Summit and Present Phase 1 Ketamir-2 Data at American Association for Cancer ...
Alvotech (NASDAQ:ALVO) reported positive findings from a pharmacokinetic trial evaluating AVT80, its experimental biosimilar to Entyvio, after the study successfully achieved all primary objectives.
SurvivorNet on MSN
Could timing give your cancer treatment a boost? New study on the best time to receive ...
A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...
A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...
Metastasis-directed therapy (MDT) significantly improved outcomes in patients with oligometastatic prostate cancer, according ...
Google will partner with Included Health to launch a nationwide randomized study evaluating how conversational artificial intelligence performs in real-world virtual care workflows. Here are four thin ...
News-Medical.Net on MSN
Natural ovulation offers a safer path to IVF success
By Dr. Sanchari Sinha Dutta, Ph.D. A landmark randomized trial shows that preparing the uterus using natural ovulation ...
Alphamab Oncology (Stock Code: 9966.HK) announced that the results from a phase III clinical study for the treatment of ...
In this randomized clinical trial, a ketogenic diet had antidepressant benefits compared with a well-matched control diet at 6 weeks. However, the clinical relevance is uncertain, as the mean effect ...
Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...
Each year, thousands of women diagnosed with breast cancer undergo surgery to remove tumors that cannot be felt by hand.
The study, which assessed the pharmacokinetics, safety, tolerability and immunogenicity of AVT80 compared to Entyvio® in ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果